A unique ultrasonic data collection system, the only one of its kind in the world

This clinical trial marks a key milestone in research, enabling the collection of unique ultrasound data for brain exploration. This advancement is the result of close collaboration between Caen Normandy University Hospital and Resolve Stroke, a company specializing in neuroimaging solutions.

The company Resolve Stroke has provided the Caen Normandy University Hospital with its new platform for assessing cerebral blood flow directly at the patient's bedside. This non-invasive technique offers real hope to critically ill patients suffering from brain injuries, helping doctors reduce the high risk of delayed complications.

Thanks to the unique architecture of the SYLVER platform, Caen Normandy University Hospital can acquire vast datasets of raw material covering a wide field of view with exceptional speed. The computing power of Nvidia graphics processors, combined with the Resolve Stroke software engine, enables the full use of ultrasound data to transform the diagnosis and treatment of neurological diseases.

All necessary authorizations from the competent French authorities have been obtained to conduct this clinical trial.

This collaboration strengthens the potential impact of the trial and guarantees access to expertise in neuro-intensive care.

Thanks to this advance, the Caen Normandy University Hospital demonstrates its commitment to supporting research in neurology.

The clinical ultrasound data collected in this study will open up new opportunities for research and development of innovative medical solutions.